Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Olaparib manufacturers

Filters

Filters

Filters , active

Country of origin : China

Clear all

None products found

olaparib

Tablets 100 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31065

This biopharmaceutical company specializes in the research, development, production, and marketing of recombinant protein therapeutics and microecological agents. They focus on treating a range of conditions including antiviral, oncology, immunology, hematology, digestive disorders, and degenerative diseases. The company boasts seven world-leading technology platforms, including recombinant protein secretion and expression, long-acting recombinant proteins, and antibody technology. Their product portfolio includes recombinant protein therapeutics such as Human Erythropoietin (EPOSINO), Human Interferon α1b (SINOGEN), and Human Granulocyte Colony-stimulating Factor (WHITE-C), as well as the microecological agent "Combined Clostridium Butyricum and Bifidobacterium (CLOBICO)". The company has a strong presence in major markets such as North America, the EU, Brazil, the Philippines, and Indonesia.

Manufacturer usually replies in 6 days

olaparib

Tablets 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #36699

Established in 2007, this manufacturer is a CTD dossier owner and manufacturer, specializing in pharmaceutical products and biological products. As a CTD dossier owner and manufacturer, it holds 47 patents and operates from its headquarters in Shanghai, China. While specific details about the number of employees, GMP approvals, and production line specifications are not available, the manufacturer is recognized as a CTD dossier owner and manufacturer.

Manufacturer usually replies in 47 days

olaparib

Tablets 100 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #18656
This China-based firm provides comprehensive regulatory and market-entry services for pharmaceutical products, offering support that spans API and finished-dosage registration, DMF and CTD preparation, clinical and marketing-authorization submissions, and the sourcing and registration of APIs, reference substances, impurities, excipients, and intermediates, while also delivering translation, dossier development, and quality-review services that assist any pharmaceutical manufacturer seeking compliance within the Chinese market.

Manufacturer usually replies in 43 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.